Literature DB >> 6086212

Gold toxicity presenting as peripheral neuropathy.

J J Weiss, G R Thompson, R Lazaro.   

Abstract

A patient with rheumatoid arthritis developed gold induced peripheral neuropathy after 255 mgs of aurothioglucose. This neuropathy is characterized by weakness and numbness of the hands and feet in association with hyperalgesia of the palmar surface of the hands. The absence of vasculitis permits differentiation of gold neuropathy from the neuritis associated with rheumatoid arthritis or systemic lupus erythematosus. Treatment consists in cessation of gold and possibly the use of dimercaprol; recovery is slow but generally complete.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6086212     DOI: 10.1007/bf02032088

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS.

Authors:  C A PALLIS; J T SCOTT
Journal:  Br Med J       Date:  1965-05-01

2.  Severe polyneuritis following gold therapy for rheumatoid arthritis.

Authors:  J B DOYLE; E F CANNON
Journal:  Ann Intern Med       Date:  1950-12       Impact factor: 25.391

3.  Rheumatoid neuropathy. Clinical and electrophysiological features.

Authors:  M A Chamberlain; F E Bruckner
Journal:  Ann Rheum Dis       Date:  1970-11       Impact factor: 19.103

4.  Gold neuropathy.

Authors:  J C Walsh
Journal:  Neurology       Date:  1970-05       Impact factor: 9.910

5.  The neurological manifestations of systemic lupus erythematosus.

Authors:  R T Johnson; E P Richardson
Journal:  Medicine (Baltimore)       Date:  1968-07       Impact factor: 1.889

6.  Generalized myokymia and gold therapy.

Authors:  H Mitsumoto; A J Wilbourn; S H Subramony
Journal:  Arch Neurol       Date:  1982-07

Review 7.  Complications of chrysotherapy: a review of recent studies.

Authors:  R B Gibbons
Journal:  Arch Intern Med       Date:  1979-03

8.  Clinical and morphological features of gold neuropathy.

Authors:  S M Katrak; M Pollock; C P O'Brien; H Nukada; S Allpress; C Calder; D G Palmer; D M Grennan; P L McCormack; M R Laurent
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.